Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Twenty One Capital Inc | Jack Mallers | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 1,607,866 | 1,633,020 | - | 0 | Class A common stock | |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.71 per share. | 09 Apr 2026 | 1,000,574 | 5,325,265 | - | 3.7 | 3,712,130 | Class A Common Stock |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.66 per share. | 09 Apr 2026 | 1,000,574 | 4,324,691 | - | 3.7 | 3,662,101 | Class A Common Stock |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.91 per share. | 09 Apr 2026 | 1,000,574 | 6,325,839 | - | 3.9 | 3,912,244 | Class A Common Stock |
| LeonaBio Inc | Mark J. Litton | Director, PRESIDENT and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 750,000 | 750,000 | - | - | Stock Option (Right to Buy) | |
| BlackBerry Ltd | John J. Giamatteo | Director, CEO & President, Secure Comm. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 732,984 | 732,984 | - | - | Restricted Share Units | |
| Zoom Video Comm Inc (Class A) | Eric S. Yuan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 561,588 | 561,588 | - | - | Restricted Stock Units | |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Apr 2026 | 422,933 | 470,457 | - | - | Class A Common Stock | |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Apr 2026 | 422,933 | 887,684 | - | - | Class A Common Stock | |
| LeonaBio Inc | Kevin Church | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| LeonaBio Inc | Mark Worthington | GENERAL COUNSEL and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| LeonaBio Inc | Robert Renninger | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Rexford Industrial Realty Inc | Howard Schwimmer | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.28 per share. | 09 Apr 2026 | 281,813 | 328,806 (0%) | 0% | 34.3 | 9,660,550 | Common Stock, par value $0.01 |
| Rexford Industrial Realty Inc | Michael S. Frankel | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.28 per share. | 09 Apr 2026 | 281,813 | 278,593 (0%) | 0% | 34.3 | 9,660,550 | Common Stock, par value $0.01 |
| Slide Insurance Holdings Inc | Bruce Lucas | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 18.11 per share. | 09 Apr 2026 | 273,702 | 37,620,933 | - | 18.1 | 4,956,743 | Common Stock |
| Slide Insurance Holdings Inc | Bruce Lucas | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 18.05 per share. | 09 Apr 2026 | 259,055 | 37,361,878 | - | 18.1 | 4,675,943 | Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Reshma P. Shetty | Director, See remarks, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 251,786 | 561,149 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Reshma P. Shetty | Director, See remarks, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 251,786 | 0 | - | - | Performance-Based Restricted Stock Unit | |
| Ginkgo Bioworks Holdings Inc (Class A) | Barry Canton | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 251,786 | 0 | - | - | Performance-Based Restricted Stock Unit | |
| Ginkgo Bioworks Holdings Inc (Class A) | Barry Canton | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 251,786 | 561,149 | - | - | Class A Common Stock | |
| Cue Biopharma Inc | Lucinda Warren | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| BlackBerry Ltd | Tim Foote | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 229,057 | 229,057 | - | - | Restricted Share Units | |
| Twenty One Capital Inc | Steven Meehan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 204,223 | 204,223 | - | 0 | Class A common stock | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Nutex Health Inc | Thomas T. Vo | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 09 Apr 2026 | 184,071 | 2,027,267 | - | 0 | Common Stock | |
| Liquidia Corp | Michael Kaseta | CFO and COO | Sale of securities on an exchange or to another person at price $ 40.24 per share. | 09 Apr 2026 | 133,789 | 411,855 (1%) | 0% | 40.2 | 5,383,388 | Common Stock |
| BlackBerry Ltd | Philip S. Kurtz | CLO & Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 130,890 | 130,890 | - | - | Restricted Share Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Reshma P. Shetty | Director, See remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.43 per share. | 09 Apr 2026 | 124,727 | 436,422 | - | 6.4 | 802,494 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Barry Canton | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.43 per share. | 09 Apr 2026 | 124,727 | 436,422 | - | 6.4 | 802,494 | Class A Common Stock |
| Porch Group Inc Ordinary | Matthew Ehrlichman | Director, CEO, CHAIRMAN AND FOUNDER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.15 per share. | 09 Apr 2026 | 121,293 | 17,309,057 | - | 7.2 | 867,439 | Common Stock |
| Twenty One Capital Inc | Jack Mallers | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.64 per share. | 09 Apr 2026 | 119,867 | 1,513,513 | - | 6.6 | 795,917 | Class A common stock |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | 09 Apr 2026 | 107,500 | 37,528,834 | - | - | Class B Common Stock | ||
| Workday (Class A) | David A. Duffield | Ten Percent Owner | 09 Apr 2026 | 107,500 | 212,549 (0%) | 0% | 0 | Class A Common Stock | ||
| Cue Biopharma Inc | Daniel G. Baker | CHIEF DEVELOPMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Hycroft Mining Holding Corp (Class A) | Eric Steven Sprott | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 38.28 per share. | 09 Apr 2026 | 100,000 | 37,303,704 | - | 38.3 | 3,828,000 | Class A common stock |
| Hycroft Mining Holding Corp (Class A) | Eric Steven Sprott | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 39.06 per share. | 09 Apr 2026 | 100,000 | 37,203,704 | - | 39.1 | 3,906,000 | Class A common stock |
| Hycroft Mining Holding Corp (Class A) | Eric Steven Sprott | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 37.84 per share. | 09 Apr 2026 | 100,000 | 37,403,704 | - | 37.8 | 3,784,000 | Class A common stock |
| BlackBerry Ltd | Jennifer Armstrong-Owen | Sr VP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 91,623 | 91,623 | - | - | Restricted Share Units | |
| Liquidia Corp | Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 86,632 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Liquidia Corp | Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.79 per share. | 09 Apr 2026 | 86,632 | 517,529 (1%) | 0% | 2.8 | 241,703 | Common Stock |
| MoonLake Immunotherapeutics (Class A) | Matthias Bodenstedt | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.94 per share. | 09 Apr 2026 | 85,870 | 1,190,435 | - | 18.9 | 1,626,378 | Class A ordinary shares, par value $0.0001 per share |
| Zymeworks BC Inc | Scott Platshon | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 76,000 | 76,000 | - | - | Performance Stock Unit | |
| Zymeworks BC Inc | Adam Schayowitz | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 76,000 | 76,000 | - | - | Performance Stock Unit | |
| Zymeworks BC Inc | Scott Platshon | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Adam Schayowitz | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Porch Group Inc Ordinary | Matthew Neagle | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.15 per share. | 09 Apr 2026 | 62,827 | 2,691,256 | - | 7.2 | 449,314 | Common Stock |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Apr 2026 | 59,208 | 270,912 | - | 0 | Common Stock | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Apr 2026 | 59,208 | 240,792 | - | 0 | Common Stock | |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Sale of securities on an exchange or to another person at price $ 3.57 per share. | 09 Apr 2026 | 50,000 | 522,551 | - | 3.6 | 178,500 | Common Stock |
| Climb Global Soln Inc | Dale Foster | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 49,590 | 344,350 (7%) | 1% | 0 | Common Stock | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Apr 2026 | 47,497 | 0 | - | 0 | Common Stock | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Apr 2026 | 47,497 | 211,704 | - | 0 | Common Stock | |
| Zymeworks BC Inc | Scott Platshon | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 47,000 | 47,000 | - | - | Restricted Stock Unit | |
| Zymeworks BC Inc | Adam Schayowitz | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 47,000 | 47,000 | - | - | Restricted Stock Unit | |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | 09 Apr 2026 | 42,443 | 878,122 (1%) | 0% | - | Class A Common Stock | ||
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | 09 Apr 2026 | 42,443 | 9,026,005 | - | - | Class B Common Stock | ||
| Mission Produce Inc | John M. Pawlowski | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 42,071 | 121,267 | - | 0 | COMMON STOCK | |
| Photronics Inc | Eric Rivera | President, CFO | Sale of securities on an exchange or to another person at price $ 44.00 per share. | 09 Apr 2026 | 40,635 | 136,173 (0%) | 0% | 44 | 1,787,940 | COMMON STOCK |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 112.93 per share. | 09 Apr 2026 | 39,607 | 113,849 (0%) | 0% | 112.9 | 4,472,937 | Class A Common Stock |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 38,118 | 9,032,733 | - | - | Class B Common Stock | |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 38,118 | 381,180 | - | - | Stock Option (Right to Buy) | |
| Lattice Semiconductor Corp | Fouad G. Tamer | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 36,926 | 318,809 (0%) | 0% | 0 | Common Stock | |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 35,715 | 9,068,448 | - | - | Class B Common Stock | |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 35,715 | 809,738 | - | - | Stock Option (Right to Buy) | |
| Twenty One Capital Inc | Jack Mallers | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 6.64 per share. | 09 Apr 2026 | 35,579 | 35,579 | - | 6.6 | 236,245 | Class A common stock |
| Braze Inc (Class A) | Susan Wiseman | General Counsel | Sale of securities on an exchange or to another person at price $ 20.29 per share. | 09 Apr 2026 | 35,000 | 209,424 | - | 20.3 | 710,150 | Class A Common Stock |
| Phreesia Inc | Chaim Indig | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.15 per share. | 09 Apr 2026 | 33,008 | 1,389,595 (3%) | 0% | 9.1 | 302,023 | Common Stock |
| Mission Produce Inc | Stephen J. Barnard | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 31,554 | 287,459 | - | 0 | COMMON STOCK | |
| Safety Shot Inc | Mitchell Rudy | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.82 per share. | 09 Apr 2026 | 31,055 | 44,198 | - | 2.8 | 87,575 | Common Stock |
| Appfolio Inc (Class A) | William Shane Trigg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 30,930 | 83,850 (0%) | 0% | 0 | Class A Common Stock | |
| Aehr Test Systems | Rhea J. Posedel | Director | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 09 Apr 2026 | 30,000 | 426,979 (1%) | 0% | 70 | 2,100,000 | Common Stock |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 111.93 per share. | 09 Apr 2026 | 29,705 | 153,456 (0%) | 0% | 111.9 | 3,324,750 | Class A Common Stock |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 111.06 per share. | 09 Apr 2026 | 29,388 | 183,161 (0%) | 0% | 111.1 | 3,263,902 | Class A Common Stock |
| LeonaBio Inc | James A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| LeonaBio Inc | John M. Fluke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| LeonaBio Inc | Grant E. Pickering | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| LeonaBio Inc | Michael A. Panzara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| LeonaBio Inc | Kelly A. Romano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| LeonaBio Inc | Barbara Kosacz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| Slide Insurance Holdings Inc | Shannon Lucas | Director, President & COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 18.11 per share. | 09 Apr 2026 | 27,069 | 1,427,069 | - | 18.1 | 490,220 | Common Stock |
| Slide Insurance Holdings Inc | Shannon Lucas | Director, President & COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 18.05 per share. | 09 Apr 2026 | 25,621 | 1,401,448 | - | 18.0 | 462,459 | Common Stock |
| Phreesia Inc | Balaji Gandhi | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.15 per share. | 09 Apr 2026 | 25,382 | 156,931 (0%) | 0% | 9.1 | 232,245 | Common Stock |
| Aehr Test Systems | Geoffrey G. Scott | Director | Sale of securities on an exchange or to another person at price $ 67.75 per share. | 09 Apr 2026 | 25,000 | 110,000 (0%) | 0% | 67.8 | 1,693,750 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.12 per share. | 09 Apr 2026 | 25,000 | 1,516,667 (5%) | 0% | 40.1 | 1,002,888 | Common Stock |
| Aehr Test Systems | Geoffrey G. Scott | Director | Sale of securities on an exchange or to another person at price $ 68.12 per share. | 09 Apr 2026 | 25,000 | 110,000 (0%) | 0% | 68.1 | 1,703,000 | Common Stock |
| Beauty Health Co (Class A) | Sheri Lewis | CSO and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.92 per share. | 09 Apr 2026 | 24,904 | 1,584,620 | - | 0.9 | 22,912 | Class A Common Stock |
| Live Nation Entertainment | Michael Rapino | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 163.66 per share. | 09 Apr 2026 | 24,904 | 4,221,882 (1%) | 0% | 163.7 | 4,075,789 | Common Stock |
| Zoom Video Comm Inc (Class A) | Michelle Chang | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 22,217 | 47,699 (0%) | 0% | 0 | Class A Common Stock | |
| Leonardo DRS Inc | John A. Baylouny | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 21,805 | 21,805 | - | - | Restricted Stock Unit | |
| Zoom Video Comm Inc (Class A) | Velchamy Sankarlingam | Pres. of Engineering & Product | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 20,752 | 166,013 | - | - | Restricted Stock Units | |
| Zoom Video Comm Inc (Class A) | Velchamy Sankarlingam | Pres. of Engineering & Product | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 20,752 | 199,856 (0%) | 0% | 0 | Class A Common Stock | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 74.60 per share. | 09 Apr 2026 | 20,000 | 595,686 (0%) | 0% | 74.6 | 1,492,096 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 74.60 per share. | 09 Apr 2026 | 20,000 | 4,398,447 (3%) | 0% | 74.6 | 1,492,076 | Common Stock |
| Phreesia Inc | Evan Roberts | President, Provider Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.15 per share. | 09 Apr 2026 | 19,626 | 842,501 (2%) | 0% | 9.2 | 179,578 | Common Stock |
| Dell | David Alan Kennedy | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 182.53 per share. | 09 Apr 2026 | 19,500 | 183,097 (0%) | 0% | 182.5 | 3,559,335 | Class C Common Stock |
| Liquidia Corp | Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 19,042 | 124,326 | - | - | Incentive Stock Option (right to buy) | |
| Liquidia Corp | Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.79 per share. | 09 Apr 2026 | 19,042 | 430,897 (1%) | 0% | 2.8 | 53,127 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 12.75 per share. | 09 Apr 2026 | 18,660 | 425,912 (0%) | 0% | 12.8 | 237,915 | Common Stock |
| Twenty One Capital Inc | Steven Meehan | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.64 per share. | 09 Apr 2026 | 18,232 | 185,991 | - | 6.6 | 121,060 | Class A common stock |
| Liquidia Corp | Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 18,115 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Liquidia Corp | Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.97 per share. | 09 Apr 2026 | 18,115 | 535,644 (1%) | 0% | 3.0 | 53,802 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 13.79 per share. | 09 Apr 2026 | 16,960 | 431,950 (0%) | 0% | 13.8 | 233,878 | Common Stock |
| Jones Lang Lasalle Inc | Christian Ulbrich | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 16,407 | 16,407 | - | - | Restricted Stock Units | |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 09 Apr 2026 | 15,972 | 15,972 (0%) | 0% | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.90 per share. | 09 Apr 2026 | 15,972 | 0 (0%) | 0% | 25.9 | 413,675 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 09 Apr 2026 | 15,972 | 30,107,847 | - | - | Class B Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 09 Apr 2026 | 15,972 | 30,107,847 | - | - | Class B Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.90 per share. | 09 Apr 2026 | 15,972 | 0 (0%) | 0% | 25.9 | 413,675 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 09 Apr 2026 | 15,972 | 15,972 (0%) | 0% | 0 | Class A Common Stock | ||
| Aehr Test Systems | Donald P. Richmond | CTO | Sale of securities on an exchange or to another person at price $ 68.68 per share. | 09 Apr 2026 | 15,751 | 199,245 (0%) | 0% | 68.7 | 1,081,856 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 12.95 per share. | 09 Apr 2026 | 15,722 | 424,512 (0%) | 0% | 13.0 | 203,600 | Common Stock |
| Phreesia Inc | Allison Hoffman | General Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.15 per share. | 09 Apr 2026 | 15,161 | 177,968 (0%) | 0% | 9.1 | 138,723 | Common Stock |
| NPK Intl Inc | Gregg S. Piontek | Senior Vice President and CFO | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 09 Apr 2026 | 15,000 | 819,326 (0%) | 0% | 15.0 | 225,675 | Common Stock |
| Climb Global Soln Inc | Charles Bass | Chief Alliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 14,877 | 128,365 (2%) | 0% | 0 | Common Stock | |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 109.06 per share. | 09 Apr 2026 | 14,743 | 863,379 (1%) | 0% | 109.1 | 1,607,873 | Class A Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 09 Apr 2026 | 14,722 | 448,910 (0%) | 0% | 7.3 | 107,029 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 14,722 | 8,109 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 14,722 | 22,831 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 09 Apr 2026 | 14,722 | 444,572 (0%) | 0% | 7.3 | 107,029 | Common Stock |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 3.38 per share. | 09 Apr 2026 | 14,500 | 518,622 | - | 3.4 | 49,010 | Common Stock |
| Phreesia Inc | Allison Hoffman | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 8.07 per share. | 09 Apr 2026 | 14,483 | 163,485 (0%) | 0% | 8.1 | 116,878 | Common Stock |
| Lattice Semiconductor Corp | Lorenzo A. Flores | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 13,979 | 119,255 (0%) | 0% | 0 | Common Stock | |
| Climb Global Soln Inc | Matthew Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 13,290 | 89,022 (1%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences | Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.26 per share. | 09 Apr 2026 | 13,000 | 52,699 (0%) | 0% | 59.3 | 770,337 | Common Stock |
| Edwards Lifesciences | Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 13,000 | 13,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Penguin Soln Inc | Joseph Clark | SVP and Pres, Optimized LED | Sale of securities on an exchange or to another person at price $ 22.55 per share. | 09 Apr 2026 | 12,546 | 99,726 (0%) | 0% | 22.5 | 282,882 | Common Stock |
| Lattice Semiconductor Corp | Esam Elashmawi | SVP Mktg & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 12,133 | 175,602 (0%) | 0% | 0 | Common Stock | |
| Leonardo DRS Inc | Michael D. Dippold | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 12,020 | 12,020 | - | - | Restricted Stock Unit | |
| Climb Global Soln Inc | Timothy Popovich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 11,902 | 58,838 (1%) | 0% | 0 | Common Stock | |
| Photronics Inc | Hsueh-Chun David Wang | SVP/COO IC & US/EU Mnstrm Ops | Sale of securities on an exchange or to another person at price $ 44.25 per share. | 09 Apr 2026 | 11,875 | 132,810 (0%) | 0% | 44.3 | 525,469 | COMMON STOCK |
| Lattice Semiconductor Corp | Pravinchandra Desale | SVP, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 11,869 | 91,827 (0%) | 0% | 0 | Common Stock | |
| Lionsgate Studios Corp | Bruce Tobey | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.45 per share. | 09 Apr 2026 | 11,637 | 285,497 | - | 10.5 | 121,607 | Common Shares |
| Lattice Semiconductor Corp | Erhaan Shaikh | SVP, Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 11,605 | 94,222 (0%) | 0% | 0 | Common Stock | |
| Hercules Cap Inc | Scott Bluestein | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.74 per share. | 09 Apr 2026 | 10,652 | 2,505,727 (2%) | 0% | 14.7 | 157,010 | Common Stock |
| Aehr Test Systems | Adil Engineer | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 09 Apr 2026 | 10,582 | 58,254 (0%) | 0% | 9.5 | 100,000 | Common Stock |
| Aehr Test Systems | Adil Engineer | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 68.15 per share. | 09 Apr 2026 | 10,582 | 47,672 (0%) | 0% | 68.1 | 721,127 | Common Stock |
| Aehr Test Systems | Adil Engineer | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 10,582 | 38,830 | - | - | Option (right to buy) | |
| Zoom Video Comm Inc (Class A) | Velchamy Sankarlingam | Pres. of Engineering & Product | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.23 per share. | 09 Apr 2026 | 10,559 | 189,297 (0%) | 0% | 83.2 | 878,826 | Class A Common Stock |
| Lattice Semiconductor Corp | Tracy Ann Feanny | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 10,550 | 66,905 (0%) | 0% | 0 | Common Stock | |
| Cintas | Robert E. Coletti | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 10,548 | 0 | - | - | Stock Option (Right to Buy) | |
| Cintas | Robert E. Coletti | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.10 per share. | 09 Apr 2026 | 10,548 | 26,744 (0%) | 0% | 27.1 | 285,851 | Common Stock |
| Twenty One Capital Inc | Jack Mallers | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.64 per share. | 09 Apr 2026 | 10,425 | 25,154 | - | 6.6 | 69,222 | Class A common stock |
| BrightSpire Cap Inc (Class A) | Michael J. Mazzei | Director, CEO | Other type of transaction at price $ 0.00 per share. | 09 Apr 2026 | 10,143 | 1,510,764 (1%) | 0% | 0 | Class A Common Stock | |
| Coya Therapeutics Inc | Mark H. Pavao | Director | 09 Apr 2026 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | ||
| Vicor Corp | Patrizio Vinciarelli | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 187.00 per share. | 09 Apr 2026 | 10,000 | 8,970,263 (31%) | 0% | 187 | 1,870,000 | Common Stock |
| Vicor Corp | Patrizio Vinciarelli | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 188.00 per share. | 09 Apr 2026 | 10,000 | 8,960,263 (31%) | 0% | 188 | 1,880,000 | Common Stock |
| Celcuity Inc | Richard J. Nigon | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Apr 2026 | 10,000 | 79,035 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 09 Apr 2026 | 10,000 | 28,876 (0%) | 0% | 135.4 | 1,354,200 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 10,000 | 102,500 | - | - | Stock Option | |
| Aehr Test Systems | Geoffrey G. Scott | Director | Sale of securities on an exchange or to another person at price $ 67.79 per share. | 09 Apr 2026 | 10,000 | 100,000 (0%) | 0% | 67.8 | 677,900 | Common Stock |
| Cirrus Logic Inc | Gregory Scott Thomas | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 9,942 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cirrus Logic Inc | Gregory Scott Thomas | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 160.11 per share. | 09 Apr 2026 | 9,942 | 30,393 (0%) | 0% | 160.1 | 1,591,814 | Common Stock |
| Cirrus Logic Inc | Gregory Scott Thomas | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.56 per share. | 09 Apr 2026 | 9,942 | 40,335 (0%) | 0% | 68.6 | 681,624 | Common Stock |
| Hercules Cap Inc | Scott Bluestein | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.74 per share. | 09 Apr 2026 | 9,741 | 2,495,986 (2%) | 0% | 14.7 | 143,582 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 09 Apr 2026 | 9,500 | 50,013 (0%) | 0% | 146.0 | 1,387,285 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 9,500 | 74,000 | - | - | Stock Option | |
| Phreesia Inc | David Linetsky | President, Network Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.15 per share. | 09 Apr 2026 | 9,454 | 232,388 (0%) | 0% | 9.1 | 86,504 | Common Stock |
| Liquidia Corp | Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.54 per share. | 09 Apr 2026 | 9,272 | 545,644 (1%) | 0% | 2.5 | 23,551 | Common Stock |
| Liquidia Corp | Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 9,272 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Phreesia Inc | Amy Beth VanDuyn | SVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.15 per share. | 09 Apr 2026 | 9,193 | 168,907 (0%) | 0% | 9.2 | 84,116 | Common Stock |
| Zoom Video Comm Inc (Class A) | Michelle Chang | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.23 per share. | 09 Apr 2026 | 8,743 | 38,956 (0%) | 0% | 83.2 | 727,680 | Class A Common Stock |
| Miami Intl Holdings Inc | John Beckelman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.00 per share. | 09 Apr 2026 | 8,667 | 8,667 | - | 12 | 104,004 | Common Stock |
| Miami Intl Holdings Inc | John Beckelman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 8,667 | 0 | - | - | Stock Option (Right to Buy) | |
| Phreesia Inc | David Linetsky | President, Network Solutions | Sale of securities on an exchange or to another person at price $ 8.07 per share. | 09 Apr 2026 | 8,332 | 224,056 (0%) | 0% | 8.1 | 67,239 | Common Stock |
| Edwards Lifesciences | Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 79.79 per share. | 09 Apr 2026 | 8,324 | 39,699 (0%) | 0% | 79.8 | 664,144 | Common Stock |
| Mission Produce Inc | Douglas M. Stone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 8,240 | 11,637 | - | 0 | COMMON STOCK | |
| Mission Produce Inc | Michael B. Sims | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 8,240 | 18,208 | - | 0 | COMMON STOCK | |
| Mission Produce Inc | Laura Jean Flanagan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 8,240 | 15,487 | - | 0 | COMMON STOCK | |
| Mission Produce Inc | Luis A. Gonzalez | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 8,240 | 49,022 | - | 0 | COMMON STOCK | |
| Mission Produce Inc | Jay A. Pack | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 8,240 | 403,965 | - | 0 | COMMON STOCK | |
| Mission Produce Inc | Bruce C. Taylor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 8,240 | 745,505 | - | 0 | COMMON STOCK | |
| Mission Produce Inc | Tony Bashir Sarsam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 8,240 | 33,270 | - | 0 | COMMON STOCK | |
| Mission Produce Inc | Linda B. Segre | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 8,240 | 65,221 | - | 0 | COMMON STOCK | |
| Dianthus Therapeutics Inc | Ryan Savitz | EVP, CFO & CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 8,224 | 71,776 | - | - | Stock Option (Right to Buy) | |
| Dianthus Therapeutics Inc | Ryan Savitz | EVP, CFO & CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.88 per share. | 09 Apr 2026 | 8,224 | 8,224 | - | 17.9 | 147,045 | Common Stock |
| Dianthus Therapeutics Inc | Ryan Savitz | EVP, CFO & CBO | Sale of securities on an exchange or to another person at price $ 89.84 per share. | 09 Apr 2026 | 8,224 | 0 | - | 89.8 | 738,844 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 8,109 | 0 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 09 Apr 2026 | 8,109 | 433,621 (0%) | 0% | 7.3 | 58,952 | Common Stock |
| Hooker Furnishings Corp | Jeremy R. Hoff | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 8,069 | 8,070 | - | - | Restricted Stock Unit (RSU) | |
| Hooker Furnishings Corp | Jeremy R. Hoff | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 8,069 | 39,017 (0%) | 0% | - | Common Stock | |
| Sunrun Inc | Maria Barak | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 13.67 per share. | 09 Apr 2026 | 8,039 | 72,963 (0%) | 0% | 13.7 | 109,879 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 75.53 per share. | 09 Apr 2026 | 7,800 | 4,418,447 (3%) | 0% | 75.5 | 589,124 | Common Stock |
| Porch Group Inc Ordinary | Shawn Tabak | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 7.15 per share. | 09 Apr 2026 | 7,734 | 416,353 | - | 7.2 | 55,310 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 75.55 per share. | 09 Apr 2026 | 7,500 | 615,686 (0%) | 0% | 75.6 | 566,661 | Common Stock |
| Leonardo DRS Inc | Mark A. Dorfman | EVP, GC and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 7,359 | 7,359 | - | - | Restricted Stock Unit | |
| Leonardo DRS Inc | Sally A. Wallace | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 7,359 | 7,359 | - | - | Restricted Stock Unit | |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 111.03 per share. | 09 Apr 2026 | 7,295 | 850,384 (1%) | 0% | 111.0 | 809,932 | Class A Common Stock |
| Atlas Lithium Corp | Igor Tkachenko | VP, Corporate Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 7,277 | 297,633 | - | 0 | Common Stock | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 73.64 per share. | 09 Apr 2026 | 7,200 | 628,486 (0%) | 0% | 73.6 | 530,240 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 73.64 per share. | 09 Apr 2026 | 7,072 | 4,431,375 (3%) | 0% | 73.6 | 520,801 | Common Stock |
| Jabil | Steven D. Borges | EVP, Global Business Units | Sale of securities on an exchange or to another person at price $ 295.00 per share. | 09 Apr 2026 | 7,000 | 76,524 (0%) | 0% | 295 | 2,065,000 | Common Stock |
| CRA Intl Inc | Paul A. Maleh | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 6,800 | 6,800 | - | - | Restricted Stock Units | |
| Kiniksa Pharma Ltd (Class A) | Michael R. Megna | CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 46.69 per share. | 09 Apr 2026 | 6,625 | 27,418 (0%) | 0% | 46.7 | 309,321 | Class A Ordinary Share |
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 6,613 | 192,936 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 09 Apr 2026 | 6,613 | 440,234 (0%) | 0% | 8.5 | 55,946 | Common Stock |
| Whitehawk Therapeutics Inc | Bryan Ball | See remarks | Sale of securities on an exchange or to another person at price $ 3.43 per share. | 09 Apr 2026 | 6,596 | 515,955 | - | 3.4 | 22,624 | Common Stock |
| Leonardo DRS Inc | Jason W. Rinsky | EVP Chief Tax and Treasury | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 5,887 | 5,887 | - | - | Restricted Stock Unit | |
| Monte Rosa Therapeutics Inc | Philip Nickson | Chief Business & Legal Officer | Sale of securities on an exchange or to another person at price $ 17.69 per share. | 09 Apr 2026 | 5,845 | 55,000 | - | 17.7 | 103,413 | Common Stock |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 110.04 per share. | 09 Apr 2026 | 5,700 | 857,679 (1%) | 0% | 110.0 | 627,217 | Class A Common Stock |
| Phreesia Inc | Yvonne Hui | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.15 per share. | 09 Apr 2026 | 5,438 | 37,364 (0%) | 0% | 9.2 | 49,758 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 74.60 per share. | 09 Apr 2026 | 5,300 | 623,186 (0%) | 0% | 74.6 | 395,403 | Common Stock |
| Zoom Video Comm Inc (Class A) | Michelle Chang | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 80.36 per share. | 09 Apr 2026 | 5,156 | 33,800 (0%) | 0% | 80.4 | 414,339 | Class A Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 74.57 per share. | 09 Apr 2026 | 5,128 | 4,426,247 (3%) | 0% | 74.6 | 382,379 | Common Stock |
| Dow | Jeff M. Fettig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 5,127 | 33,157 (0%) | 0% | 0 | Common Stock | |
| Dow | Richard K. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 5,127 | 55,299 (0%) | 0% | 0 | Common Stock | |
| Dow | Samuel R. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 5,127 | 32,522 (0%) | 0% | 0 | Common Stock | |
| Dow | Wesley G. Bush | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 5,127 | 33,800 (0%) | 0% | 0 | Common Stock | |
| Dow | Jerri L. DeVard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 5,127 | 21,850 (0%) | 0% | 0 | Common Stock | |
| Dow | Gaurdie E. Banister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 5,127 | 27,492 (0%) | 0% | 0 | Common Stock | |
| Dow | Daniel W. Yohannes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 5,127 | 34,880 (0%) | 0% | 0 | Common Stock | |
| Dow | Jill S. Wyant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 5,127 | 29,777 (0%) | 0% | 0 | Common Stock | |
| Dow | Jacqueline C. Hinman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 5,127 | 33,157 (0%) | 0% | 0 | Common Stock | |
| Dow | Luis Alberto Moreno Mejia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 5,127 | 24,716 (0%) | 0% | 0 | Common Stock | |
| Dow | Debra L. Dial | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 5,127 | 24,716 (0%) | 0% | 0 | Common Stock | |
| Better Home & Finance Holding Co. (Class A) | Harit Talwar | Director | Purchase of securities on an exchange or from another person at price $ 32.89 per share. | 09 Apr 2026 | 5,000 | 36,698 | - | 32.9 | 164,432 | Class A Common Stock |
| Aehr Test Systems | Geoffrey G. Scott | Director | Sale of securities on an exchange or to another person at price $ 67.90 per share. | 09 Apr 2026 | 5,000 | 105,000 (0%) | 0% | 67.9 | 339,500 | Common Stock |
| Aehr Test Systems | Geoffrey G. Scott | Director | Sale of securities on an exchange or to another person at price $ 68.00 per share. | 09 Apr 2026 | 5,000 | 135,000 (0%) | 0% | 68 | 340,000 | Common Stock |
| Hippo Holdings Inc | Rick Mccathron | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.05 per share. | 09 Apr 2026 | 5,000 | 610,650 | - | 26.1 | 130,250 | Common Stock |
| Photronics Inc | Kang Jyh Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.60 per share. | 09 Apr 2026 | 5,000 | 390,850 (0%) | 0% | 8.6 | 43,000 | COMMON STOCK |
| Photronics Inc | Kang Jyh Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 5,000 | 5,000 | - | - | PHOTRONICS STOCK OPTIONS | |
| Photronics Inc | Kang Jyh Lee | Director | Sale of securities on an exchange or to another person at price $ 44.00 per share. | 09 Apr 2026 | 5,000 | 385,850 (0%) | 0% | 44 | 220,000 | COMMON STOCK |
| Aehr Test Systems | Geoffrey G. Scott | Director | Sale of securities on an exchange or to another person at price $ 68.00 per share. | 09 Apr 2026 | 5,000 | 135,000 (0%) | 0% | 68 | 340,000 | Common Stock |
| Zoom Video Comm Inc (Class A) | Velchamy Sankarlingam | Pres. of Engineering & Product | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 4,845 | 0 | - | - | Performance-vesting RSU | |
| Zoom Video Comm Inc (Class A) | Velchamy Sankarlingam | Pres. of Engineering & Product | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 4,845 | 194,142 (0%) | 0% | 0 | Class A Common Stock | |
| Nutex Health Inc | Thomas T. Vo | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 4,841 | 16,507 | - | - | Restricted Stock Units | |
| Vicor Corp | Patrizio Vinciarelli | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 186.00 per share. | 09 Apr 2026 | 4,721 | 8,980,263 (31%) | 0% | 186 | 878,106 | Common Stock |
| Edwards Lifesciences | Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 80.50 per share. | 09 Apr 2026 | 4,676 | 48,023 (0%) | 0% | 80.5 | 376,401 | Common Stock |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 111.88 per share. | 09 Apr 2026 | 4,606 | 845,778 (1%) | 0% | 111.9 | 515,335 | Class A Common Stock |
| Powell Industries Inc | Brett A. Cope | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 233.96 per share. | 09 Apr 2026 | 4,440 | 164,851 (1%) | 0% | 234.0 | 1,038,782 | Common Stock |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 113.10 per share. | 09 Apr 2026 | 4,100 | 841,678 (1%) | 0% | 113.1 | 463,696 | Class A Common Stock |
| Leonardo DRS Inc | Pamela J. Morrow | SVP and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 4,089 | 4,089 | - | - | Restricted Stock Unit | |
| Nike | John W. Rogers | Director | Purchase of securities on an exchange or from another person at price $ 43.34 per share. | 09 Apr 2026 | 4,000 | 41,022 (0%) | 0% | 43.3 | 173,360 | Class B Common Stock |
| Village Super Market Inc (Class A) | Luigi Perri | VP of Finance & CAO | Sale of securities on an exchange or to another person at price $ 45.04 per share. | 09 Apr 2026 | 3,719 | 15,839 (0%) | 0% | 45.0 | 167,519 | CLASS A COMMON STOCK |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 116.13 per share. | 09 Apr 2026 | 3,700 | 105,049 (0%) | 0% | 116.1 | 429,674 | Class A Common Stock |
| Oscar Health Inc (Class A) | Jeffery H. Boyd | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 3,610 | 69,858 | - | - | Deferred Stock Unit | |
| Hercules Cap Inc | Seth H. Meyer | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.74 per share. | 09 Apr 2026 | 3,458 | 445,090 (0%) | 0% | 14.7 | 50,971 | Common Stock |
| Micron Tech | Michael D. Cordano | EVP, Worldwide Sales | Sale of securities on an exchange or to another person at price $ 420.81 per share. | 09 Apr 2026 | 3,407 | 47,466 (0%) | 0% | 420.8 | 1,433,700 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.08 per share. | 09 Apr 2026 | 3,338 | 421,174 (0%) | 0% | 14.1 | 46,999 | Common Stock |
| Mission Produce Inc | Luis A. Gonzalez | Director, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.70 per share. | 09 Apr 2026 | 3,271 | 45,751 | - | 14.7 | 48,084 | COMMON STOCK |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 115.16 per share. | 09 Apr 2026 | 3,200 | 108,749 (0%) | 0% | 115.2 | 368,522 | Class A Common Stock |
| Kymera Therapeutics Inc | Noah Goodman | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 86.62 per share. | 09 Apr 2026 | 3,094 | 58,712 | - | 86.6 | 267,996 | Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 3,093 | 8,309 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 09 Apr 2026 | 3,093 | 68,697 | - | 27.8 | 86,140 | Class A Common Stock |
| Hooker Furnishings Corp | Jeremy R. Hoff | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.00 per share. | 09 Apr 2026 | 3,075 | 35,942 (0%) | 0% | 15 | 46,125 | Common Stock |
| AstroNova Inc | Alexis P. Michas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 3,053 | 29,319 (0%) | 0% | 0 | Common Stock | |
| TD Synnex Corp | Miriam Anne Murphy | President, Europe | Sale of securities on an exchange or to another person at price $ 200.14 per share. | 09 Apr 2026 | 3,025 | 10,820 (0%) | 0% | 200.1 | 605,424 | Common Stock |
| Hercules Cap Inc | Seth H. Meyer | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.74 per share. | 09 Apr 2026 | 3,011 | 442,079 (0%) | 0% | 14.7 | 44,382 | Common Stock |
| AstroNova Inc | Mitchell I. Quain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 3,007 | 108,910 (1%) | 0% | 0 | Common Stock | |
| Aehr Test Systems | Laura Oliphant | Director | Sale of securities on an exchange or to another person at price $ 68.36 per share. | 09 Apr 2026 | 3,000 | 4,665 (0%) | 0% | 68.4 | 205,073 | Common Stock |
| AstroNova Inc | Yvonne E. Schlaeppi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 2,873 | 51,920 (0%) | 0% | 0 | Common Stock | |
| AstroNova Inc | Richard S. Warzala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 2,827 | 75,711 (1%) | 0% | 0 | Common Stock | |
| AstroNova Inc | Shawn W. Kravetz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 2,760 | 9,464 (0%) | 0% | 0 | Common Stock | |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 113.86 per share. | 09 Apr 2026 | 2,699 | 838,979 (1%) | 0% | 113.9 | 307,321 | Class A Common Stock |
| Kymera Therapeutics Inc | Noah Goodman | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 87.11 per share. | 09 Apr 2026 | 2,670 | 56,042 | - | 87.1 | 232,586 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 49.89 per share. | 09 Apr 2026 | 2,597 | 125,694 (0%) | 0% | 49.9 | 129,562 | Common Stock |
| Aehr Test Systems | Adil Engineer | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 66.31 per share. | 09 Apr 2026 | 2,528 | 42,641 (0%) | 0% | 66.3 | 167,644 | Common Stock |
| Aehr Test Systems | Adil Engineer | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 68.34 per share. | 09 Apr 2026 | 2,503 | 45,169 (0%) | 0% | 68.3 | 171,055 | Common Stock |
| Concentrix Corp | Andre S. Valentine | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 27.95 per share. | 09 Apr 2026 | 2,500 | 89,066 | - | 27.9 | 69,869 | Common Stock |
| Kymera Therapeutics Inc | Noah Goodman | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 2,500 | 97,500 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Noah Goodman | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 89.00 per share. | 09 Apr 2026 | 2,500 | 53,542 | - | 89 | 222,500 | Common Stock |
| Kymera Therapeutics Inc | Noah Goodman | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.05 per share. | 09 Apr 2026 | 2,500 | 61,806 | - | 21.1 | 52,625 | Common Stock |
| Semtech Corp | Martin S.J. Burvill | Director | Sale of securities on an exchange or to another person at price $ 88.98 per share. | 09 Apr 2026 | 2,500 | 4,409 (0%) | 0% | 89.0 | 222,449 | Common Stock |
| Zoom Video Comm Inc (Class A) | Velchamy Sankarlingam | Pres. of Engineering & Product | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.23 per share. | 09 Apr 2026 | 2,466 | 191,676 (0%) | 0% | 83.2 | 205,245 | Class A Common Stock |
| GSK PLC (ADR) | Luke Miels | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 21.50 per share. | 09 Apr 2026 | 2,393 | 1,480,419 (0%) | 0% | 21.5 | 51,459 | Ords 0.31p |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 104.27 per share. | 09 Apr 2026 | 2,193 | 66,504 | - | 104.3 | 228,664 | Class A Common Stock |
| Mineralys Therapeutics Inc | David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 27.38 per share. | 09 Apr 2026 | 2,170 | 76,140 | - | 27.4 | 59,415 | Common Stock |
| Mineralys Therapeutics Inc | David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 2,170 | 21,706 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 09 Apr 2026 | 2,170 | 78,310 | - | 16 | 34,720 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.44 per share. | 09 Apr 2026 | 2,100 | 429,850 (0%) | 0% | 14.4 | 30,324 | Common Stock |
| Exzeo Group Inc | Paresh Patel | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 15.74 per share. | 09 Apr 2026 | 2,000 | 1,606,013 | - | 15.7 | 31,480 | Common Stock |
| Kymera Therapeutics Inc | Noah Goodman | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 87.35 per share. | 09 Apr 2026 | 2,000 | 51,542 | - | 87.4 | 174,700 | Common Stock |
| Cintas | Robert E. Coletti | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.86 per share. | 09 Apr 2026 | 1,996 | 16,196 (0%) | 0% | 26.9 | 53,613 | Common Stock |
| Cintas | Robert E. Coletti | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 1,996 | 0 | - | - | Stock Option (Right to Buy) | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 575.53 per share. | 09 Apr 2026 | 1,956 | 26,360 (0%) | 0% | 575.5 | 1,125,731 | Common Stock |
| MoonLake Immunotherapeutics (Class A) | Matthias Bodenstedt | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.51 per share. | 09 Apr 2026 | 1,925 | 1,188,510 | - | 19.5 | 37,557 | Class A ordinary shares, par value $0.0001 per share |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 113.71 per share. | 09 Apr 2026 | 1,900 | 111,949 (0%) | 0% | 113.7 | 216,053 | Class A Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 577.90 per share. | 09 Apr 2026 | 1,815 | 44,219 (0%) | 0% | 577.9 | 1,048,893 | Common Stock |
| Bank First Corp | Kevin M. LeMahieu | Chief Financial Officer | Gift of securities by or to the insider at price $ 142.61 per share. | 09 Apr 2026 | 1,785 | 22,021 (0%) | 0% | 142.6 | 254,559 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 580.64 per share. | 09 Apr 2026 | 1,756 | 19,038 (0%) | 0% | 580.6 | 1,019,602 | Common Stock |
| Kiniksa Pharma Ltd (Class A) | Ross Moat | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 46.69 per share. | 09 Apr 2026 | 1,703 | 12,029 (0%) | 0% | 46.7 | 79,513 | Class A Ordinary Share |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 577.77 per share. | 09 Apr 2026 | 1,617 | 23,157 (0%) | 0% | 577.8 | 934,247 | Common Stock |
| Westwood Holdings Grp Inc | Susan M. Byrne | Director Emerita | Sale of securities on an exchange or to another person at price $ 16.32 per share. | 09 Apr 2026 | 1,600 | 299,045 (3%) | 0% | 16.3 | 26,114 | common stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 576.63 per share. | 09 Apr 2026 | 1,586 | 24,774 (0%) | 0% | 576.6 | 914,530 | Common Stock |
| CRA Intl Inc | Chad M. Holmes | EVP AND CHIEF CORP DEV OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 1,579 | 1,579 | - | - | Restricted Stock Units | |
| Ingredion Inc | Stephan B. Tanda | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Apr 2026 | 1,557 | 10,357 (0%) | 0% | 0 | Common Stock | |
| Ingredion Inc | Stephan B. Tanda | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Apr 2026 | 1,557 | 380 (0%) | 0% | 0 | Common Stock | |
| Zoom Video Comm Inc (Class A) | Michelle Chang | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 82.79 per share. | 09 Apr 2026 | 1,500 | 31,500 (0%) | 0% | 82.8 | 124,191 | Class A Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 580.84 per share. | 09 Apr 2026 | 1,482 | 40,551 (0%) | 0% | 580.8 | 860,807 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 576.69 per share. | 09 Apr 2026 | 1,478 | 46,034 (0%) | 0% | 576.7 | 852,354 | Common Stock |
| Oscar Health Inc (Class A) | David Plouffe Alexander | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 1,461 | 6,854 | - | - | Deferred Stock Unit | |
| Hercules Cap Inc | Christian Follmann | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.74 per share. | 09 Apr 2026 | 1,433 | 147,337 (0%) | 0% | 14.7 | 21,122 | Common Stock |
| Oscar Health Inc (Class A) | William Gassen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 1,418 | 6,387 | - | - | Deferred Stock Unit | |
| Microstrategy Inc (Class A) | Jarrod M. Patten | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.65 per share. | 09 Apr 2026 | 1,400 | 29,400 (0%) | 0% | 18.7 | 26,116 | Class A Common Stock |
| Microstrategy Inc (Class A) | Jarrod M. Patten | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 1,400 | 43,700 | - | - | Director Stock Option (Right to buy) | |
| Microstrategy Inc (Class A) | Jarrod M. Patten | Director | Sale of securities on an exchange or to another person at price $ 130.08 per share. | 09 Apr 2026 | 1,400 | 28,000 (0%) | 0% | 130.1 | 182,105 | Class A Common Stock |
| CRA Intl Inc | Jonathan Yellin | EVP AND GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 1,396 | 1,396 | - | - | Restricted Stock Units | |
| Hercules Cap Inc | Christian Follmann | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.74 per share. | 09 Apr 2026 | 1,365 | 148,770 (0%) | 0% | 14.7 | 20,120 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 575.04 per share. | 09 Apr 2026 | 1,260 | 48,753 (0%) | 0% | 575.0 | 724,545 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 575.75 per share. | 09 Apr 2026 | 1,241 | 47,512 (0%) | 0% | 575.8 | 714,509 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 579.75 per share. | 09 Apr 2026 | 1,224 | 20,794 (0%) | 0% | 579.7 | 709,613 | Common Stock |
| Ally Fin Inc | Thomas P. Gibbons | Director | Grant, award, or other acquisition of securities at price $ 39.23 per share. | 09 Apr 2026 | 1,211 | 21,396 (0%) | 0% | 39.2 | 47,508 | Common Stock |
| Oscar Health Inc (Class A) | Siddhartha Sankaran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 1,203 | 1,203 | - | - | Deferred Stock Unit | |
| Aehr Test Systems | Adil Engineer | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 66.27 per share. | 09 Apr 2026 | 1,200 | 41,441 (0%) | 0% | 66.3 | 79,524 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 578.83 per share. | 09 Apr 2026 | 1,140 | 43,079 (0%) | 0% | 578.8 | 659,864 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 578.52 per share. | 09 Apr 2026 | 1,139 | 22,018 (0%) | 0% | 578.5 | 658,939 | Common Stock |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 117.45 per share. | 09 Apr 2026 | 1,100 | 836,379 (1%) | 0% | 117.4 | 129,190 | Class A Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 580.07 per share. | 09 Apr 2026 | 1,046 | 42,033 (0%) | 0% | 580.1 | 606,752 | Common Stock |
| Zoom Video Comm Inc (Class A) | Michelle Chang | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 84.00 per share. | 09 Apr 2026 | 1,033 | 30,467 (0%) | 0% | 84.0 | 86,773 | Class A Common Stock |
| Hercules Cap Inc | Kiersten Zaza Botelho | Chief Legal Officer & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.74 per share. | 09 Apr 2026 | 1,018 | 91,362 (0%) | 0% | 14.7 | 15,005 | Common Stock |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 116.23 per share. | 09 Apr 2026 | 1,000 | 837,479 (1%) | 0% | 116.2 | 116,234 | Class A Common Stock |
| Broadcom | Gayla J. Delly | Director | Sale of securities on an exchange or to another person at price $ 358.31 per share. | 09 Apr 2026 | 1,000 | 32,352 (0%) | 0% | 358.3 | 358,310 | Common Stock, $0.001 par value |
| Hercules Cap Inc | Kiersten Zaza Botelho | Chief Legal Officer & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.74 per share. | 09 Apr 2026 | 956 | 92,380 (0%) | 0% | 14.7 | 14,091 | Common Stock |
| Phreesia Inc | David Linetsky | President, Network Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.15 per share. | 09 Apr 2026 | 914 | 12,363 (0%) | 0% | 9.1 | 8,363 | Common Stock |
| CRA Intl Inc | Eric Nierenberg | EVP, CFO AND TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 911 | 911 | - | - | Restricted Stock Units | |
| CRA Intl Inc | Brian Langan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 911 | 911 | - | - | Restricted Stock Units | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 105.00 per share. | 09 Apr 2026 | 900 | 65,604 | - | 105 | 94,500 | Class A Common Stock |
| Westwood Holdings Grp Inc | Susan M. Byrne | Director Emerita | Sale of securities on an exchange or to another person at price $ 16.11 per share. | 09 Apr 2026 | 900 | 300,645 (3%) | 0% | 16.1 | 14,495 | common stock |
| Photronics Inc | Eric Rivera | President, CFO | Sale of securities on an exchange or to another person at price $ 44.00 per share. | 09 Apr 2026 | 882 | 176,808 (0%) | 0% | 44 | 38,808 | COMMON STOCK |
| Ally Fin Inc | David Reilly | Director | Grant, award, or other acquisition of securities at price $ 39.23 per share. | 09 Apr 2026 | 829 | 32,430 (0%) | 0% | 39.2 | 32,522 | Common Stock |
| Zoom Video Comm Inc (Class A) | Michelle Chang | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 81.28 per share. | 09 Apr 2026 | 800 | 33,000 (0%) | 0% | 81.3 | 65,027 | Class A Common Stock |
| eXoZymes Inc | Tyler Korman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.04 per share. | 09 Apr 2026 | 750 | 729,873 | - | 10.0 | 7,530 | COMMON STOCK |
| eXoZymes Inc | Tyler Korman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.53 per share. | 09 Apr 2026 | 750 | 729,123 | - | 10.5 | 7,894 | COMMON STOCK |
| Liquidia Corp | Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.54 per share. | 09 Apr 2026 | 728 | 536,372 (1%) | 0% | 2.5 | 1,849 | Common Stock |
| Liquidia Corp | Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 728 | 0 | - | - | Incentive Stock Option (right to buy) | |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 118.24 per share. | 09 Apr 2026 | 700 | 835,679 (1%) | 0% | 118.2 | 82,767 | Class A Common Stock |
| Consumer Portfolio Service Inc | Teri L. Robinson | Exec. Vice President | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Apr 2026 | 660 | 496,465 (2%) | 0% | 0 | Common Stock, no par value | |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 29.46 per share. | 09 Apr 2026 | 626 | 82,458 (0%) | 0% | 29.5 | 18,445 | Ords 0.31p |
| Rockwell | Cyril Perducat | SVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 581 | 6,439 (0%) | 0% | 0 | Common Stock | |
| Rockwell | Cyril Perducat | SVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 581 | 582 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 574.87 per share. | 09 Apr 2026 | 560 | 28,316 (0%) | 0% | 574.9 | 321,926 | Common Stock |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 115.02 per share. | 09 Apr 2026 | 500 | 838,479 (1%) | 0% | 115.0 | 57,509 | Class A Common Stock |
| Microstrategy Inc (Class A) | Jarrod M. Patten | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 500 | 43,200 | - | - | Director Stock Option (Right to buy) | |
| Microstrategy Inc (Class A) | Jarrod M. Patten | Director | Sale of securities on an exchange or to another person at price $ 132.00 per share. | 09 Apr 2026 | 500 | 28,000 (0%) | 0% | 132 | 66,000 | Class A Common Stock |
| Microstrategy Inc (Class A) | Jarrod M. Patten | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.65 per share. | 09 Apr 2026 | 500 | 28,500 (0%) | 0% | 18.7 | 9,327 | Class A Common Stock |
| Westwood Holdings Grp Inc | Susan M. Byrne | Director Emerita | Sale of securities on an exchange or to another person at price $ 16.31 per share. | 09 Apr 2026 | 401 | 301,545 (3%) | 0% | 16.3 | 6,539 | common stock |
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 13.48 per share. | 09 Apr 2026 | 400 | 425,512 (0%) | 0% | 13.5 | 5,392 | Common Stock |
| Aehr Test Systems | Adil Engineer | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.43 per share. | 09 Apr 2026 | 386 | 41,055 (0%) | 0% | 70.4 | 27,186 | Common Stock |
| Owens Corning | John D. Williams | Director | Grant, award, or other acquisition of securities at price $ 114.99 per share. | 09 Apr 2026 | 367 | 53,789 (0%) | 0% | 115.0 | 42,203 | $.01 Par Value Common |
| Owens Corning | Edward F. Lonergan | Director | Grant, award, or other acquisition of securities at price $ 115.12 per share. | 09 Apr 2026 | 350 | 53,353 (0%) | 0% | 115.1 | 40,293 | $.01 Par Value Common |
| Joby Aviation Inc | Didier Papadopoulos | President of Aircraft OEM | Sale of securities on an exchange or to another person at price $ 8.47 per share. | 09 Apr 2026 | 271 | 144,788 | - | 8.5 | 2,295 | Common Stock |
| Vicor Corp | Patrizio Vinciarelli | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 189.00 per share. | 09 Apr 2026 | 222 | 8,960,041 (31%) | 0% | 189 | 41,958 | Common Stock |
| CSW Industrials Inc | Fang Wang | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 211 | 211 | - | - | Performance Rights | |
| Rockwell | Cyril Perducat | SVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 394.99 per share. | 09 Apr 2026 | 198 | 6,241 (0%) | 0% | 395.0 | 78,209 | Common Stock |
| Verizon Communincations | Daniel H. Schulman | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 195 | 6,979 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Hans Erik Vestberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 195 | 225,010 | - | - | Phantom Stock (unitized) | |
| GSK PLC (ADR) | Vishal Sikka | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 29.46 per share. | 09 Apr 2026 | 192 | 25,854 (0%) | 0% | 29.5 | 5,657 | Ords 0.31p |
| Owens Corning | Maryann T. Mannen | Director | Grant, award, or other acquisition of securities at price $ 114.96 per share. | 09 Apr 2026 | 163 | 27,410 (0%) | 0% | 115.0 | 18,738 | $.01 Par Value Common |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 582.30 per share. | 09 Apr 2026 | 162 | 18,876 (0%) | 0% | 582.3 | 94,333 | Common Stock |
| Owens Corning | Suzanne P. Nimocks | Director | Grant, award, or other acquisition of securities at price $ 114.96 per share. | 09 Apr 2026 | 140 | 36,093 (0%) | 0% | 115.0 | 16,095 | $.01 Par Value Common |
| Verizon Communincations | Anthony T. Skiadas | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 127 | 141,470 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 127 | 410,769 | - | - | Phantom Stock (unitized) | |
| Owens Corning | Adrienne D. Elsner | Director | Grant, award, or other acquisition of securities at price $ 115.84 per share. | 09 Apr 2026 | 124 | 18,307 (0%) | 0% | 115.8 | 14,364 | $.01 Par Value Common |
| Science Applications Intl Corp | Srinivas Attili | EVP, Civilian | Purchase of securities on an exchange or from another person at price $ 94.96 per share. | 09 Apr 2026 | 100 | 17,656 (0%) | 0% | 95.0 | 9,496 | Common Stock |
| Owens Corning | Jose Mendez-Andino | EVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 115.54 per share. | 09 Apr 2026 | 100 | 24,430 (0%) | 0% | 115.5 | 11,554 | $.01 Par Value Common |
| Barclays PLC (ADR) | Anna Cross | Executive Director,Finance Director | Sale or transfer of securities back to the company at price $ 4.10 per share. | 09 Apr 2026 | 98 | 1,415,864 (0%) | 0% | 4.1 | 402 | Ords 0.25p |
| Verizon Communincations | Vandana Venkatesh | EVP and Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 93 | 55,315 | - | - | Phantom Stock (unitized) | |
| Owens Corning | Alfred E. Festa | Director | Grant, award, or other acquisition of securities at price $ 115.44 per share. | 09 Apr 2026 | 85 | 12,506 (0%) | 0% | 115.4 | 9,812 | $.01 Par Value Common |
| Owens Corning | Eduardo E. Cordeiro | Director | Grant, award, or other acquisition of securities at price $ 115.68 per share. | 09 Apr 2026 | 84 | 15,517 (0%) | 0% | 115.7 | 9,717 | $.01 Par Value Common |
| Verizon Communincations | Joseph J. Russo | EVP&Pres-Global Networks&Tech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 80 | 81,612 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Rodriguez Alfonso Villanueva | EVP&Int.Group CEO-VZ Cons.&CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 76 | 6,008 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Samantha Hammock L. | EVP & Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 72 | 35,329 | - | - | Phantom Stock (unitized) | |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 29.47 per share. | 09 Apr 2026 | 64 | 8,398 (0%) | 0% | 29.5 | 1,886 | Ords 0.31p |
| GSK PLC (ADR) | Harry C Dietz | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 29.47 per share. | 09 Apr 2026 | 60 | 8,148 (0%) | 0% | 29.5 | 1,768 | Ords 0.31p |
| Owens Corning | Paul E. Martin | Director | Grant, award, or other acquisition of securities at price $ 114.96 per share. | 09 Apr 2026 | 52 | 7,618 (0%) | 0% | 115.0 | 5,978 | $.01 Par Value Common |
| GSK PLC (ADR) | Hal V Barron | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 29.46 per share. | 09 Apr 2026 | 52 | 1,204,304 (0%) | 0% | 29.5 | 1,532 | Ords 0.31p |
| GSK PLC (ADR) | Elizabeth McKee Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 29.46 per share. | 09 Apr 2026 | 52 | 6,906 (0%) | 0% | 29.5 | 1,532 | Ords 0.31p |
| Verizon Communincations | Mary-Lee Stillwell | SVP and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 42 | 16,176 | - | - | Phantom Stock (unitized) | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 581.45 per share. | 09 Apr 2026 | 38 | 40,513 (0%) | 0% | 581.4 | 22,095 | Common Stock |
| GSK PLC (ADR) | Jeannie Lee | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 29.46 per share. | 09 Apr 2026 | 28 | 4,000 (0%) | 0% | 29.5 | 825 | Ords 0.31p |
| GSK PLC (ADR) | Luke Miels | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 21.50 per share. | 09 Apr 2026 | 2 | 1,478,026 (0%) | 0% | 21.5 | 43 | Ords 0.31p |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.